Loss of nuclear TDP‐43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones

Loss of nuclear TDP‐43 characterizes sporadic and most familial forms of amyotrophic lateral sclerosis (ALS). TDP‐43 (encoded by TARDBP) has multiple roles in RNA processing. We aimed to determine whether (1) RNA splicing dysregulation is present in lower motor neurones in ALS and in a motor neurone‐like cell model; and (2) TARDBP mutations (mtTARDBP) are associated with aberrant RNA splicing using patient‐derived fibroblasts.

[1]  L. Pellizzoni,et al.  Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs , 2007, PloS one.

[2]  John Q Trojanowski,et al.  Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[3]  Gene W. Yeo,et al.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 , 2011, Nature Neuroscience.

[4]  T. Dörk,et al.  Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping , 2001, The EMBO journal.

[5]  Andrea D'Ambrogio,et al.  Structural determinants of the cellular localization and shuttling of TDP-43 , 2008, Journal of Cell Science.

[6]  R. Raman,et al.  Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions , 2015, Neuropathology and applied neurobiology.

[7]  J. Ule,et al.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. , 2011, Nature neuroscience.

[8]  A. Krainer,et al.  Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly , 2011, Proceedings of the National Academy of Sciences.

[9]  E. Buratti,et al.  TDP-43: gumming up neurons through protein-protein and protein-RNA interactions. , 2012, Trends in biochemical sciences.

[10]  B. Frey,et al.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.

[11]  M. Nishizawa,et al.  Minor splicing pathway is not minor any more: Implications for the pathogenesis of motor neuron diseases , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  Gene W. Yeo,et al.  Misregulated RNA processing in amyotrophic lateral sclerosis , 2012, Brain Research.

[13]  Lili Wan,et al.  SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing , 2008, Cell.

[14]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[15]  J. Trojanowski,et al.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. , 2011, The Journal of clinical investigation.

[16]  R. Durbin,et al.  A computational scan for U12-dependent introns in the human genome sequence. , 2001, Nucleic acids research.

[17]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[18]  Aaron A Hoskins,et al.  The spliceosome: a flexible, reversible macromolecular machine. , 2012, Trends in biochemical sciences.

[19]  E. Buratti,et al.  Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene , 2005, Nucleic acids research.

[20]  P. Grabowski,et al.  U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon. , 1992, Genes & development.

[21]  C. Ponting,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[22]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[23]  Crispin J. Miller,et al.  High correspondence between Affymetrix exon and standard expression arrays. , 2007, BioTechniques.

[24]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[25]  E. Marcotte,et al.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.

[26]  J. Highley,et al.  Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology , 2011, Acta Neuropathologica.

[27]  A. Kakita,et al.  Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[28]  A. Zell,et al.  TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR , 2011, Nucleic acids research.

[29]  J. Schulz,et al.  TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity , 2010, PloS one.

[30]  Murray Grossman,et al.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.

[31]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[32]  J. Bonfield,et al.  Finishing the euchromatic sequence of the human genome , 2004, Nature.

[33]  Tyson A. Clark,et al.  Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array , 2006, BMC Genomics.

[34]  S. Lindquist,et al.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity , 2008, Proceedings of the National Academy of Sciences.

[35]  K. Jellinger,et al.  Ageing and Dementia , 1998, Journal of Neural Transmission. Supplementa.

[36]  J. Eberwine,et al.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Biamonti,et al.  Cellular stress and RNA splicing. , 2009, Trends in biochemical sciences.

[38]  Janice L. Holton,et al.  Diseases of movement and system degenerations , 2008 .

[39]  M. Carmo-Fonseca,et al.  The spliceosome: a self-organized macromolecular machine in the nucleus? , 2009, Trends in cell biology.

[40]  G. Rouleau,et al.  Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. , 2010, Human molecular genetics.

[41]  E. Rogaeva,et al.  RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS , 2011, Molecular and Cellular Neuroscience.

[42]  J. Highley,et al.  Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. , 2010, Archives of neurology.

[43]  Crispin J. Miller,et al.  A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling , 2010, BMC Genomics.

[44]  E. Buratti,et al.  UG repeats/TDP-43 interactions near 5' splice sites exert unpredictable effects on splicing modulation. , 2012, Journal of molecular biology.

[45]  Frederick P. Roth,et al.  Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes , 2010, The Journal of Biological Chemistry.

[46]  Harry Zuzan,et al.  Heritability of alternative splicing in the human genome. , 2007, Genome research.